Beam Therapeutics Inc. (BEAM) insider trading

By person

7 insiders · 33 transactions

36.5×

John Evans holds 36.5 times base salary in stock. $27.59M of shares against $755.00K in salary for 2025.

Salary from the company's own proxy. The shares are what John Evans last reported holding, valued at $23.98, the price Common Stock was last bought or sold at on the open market here, on 16 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Fmr LLC entity

10% owner

—

$10.04M (2)

−$10.04M

854,583

0.8274%

$20.50M

−64.7%

John M. Evans

CEO

—

$6.24M (13) scheduled

−$6.24M

1,150,205

1.11%

$27.59M

+7.2%

Giuseppe Ciaramella

President

—

$1.41M (2) scheduled

−$1.41M

253,911

0.2458%

$6.09M

−10.5%

Christine Bellon

Chief Legal Officer

—

$871.83K (6) scheduled

−$871.83K

109,711

0.1062%

$2.63M

+5.3%

Amy Simon

Chief Medical Officer

—

$606.68K (3) scheduled

−$606.68K

85,696

0.0830%

$2.06M

+23.3%

Bethany J Cavanagh

SVP, Finance and Treasurer

—

$392.57K (4) scheduled

−$392.57K

50,984

0.0494%

$1.22M

+14.5%

Sravan Kumar Emany

Chief Financial Officer

—

$170.57K (1) scheduled

−$170.57K

105,456

0.1021%

$2.53M

—

Beam Therapeutics Inc.

What the insiders did Net selling

By person